VisionPoint Advisory Group LLC Has $103,000 Position in STERIS plc (NYSE:STE)

VisionPoint Advisory Group LLC boosted its stake in STERIS plc (NYSE:STE) by 19.9% in the fourth quarter, HoldingsChannel reports. The firm owned 507 shares of the medical equipment provider’s stock after buying an additional 84 shares during the period. VisionPoint Advisory Group LLC’s holdings in STERIS were worth $103,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. grew its stake in shares of STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after buying an additional 529,308 shares during the period. Assetmark Inc. boosted its holdings in STERIS by 24.6% in the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider’s stock worth $3,252,000 after acquiring an additional 2,647 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in STERIS by 30.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock valued at $2,275,000 after acquiring an additional 2,583 shares during the period. KBC Group NV increased its holdings in shares of STERIS by 52.0% during the third quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider’s stock valued at $2,928,000 after acquiring an additional 4,132 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of STERIS during the third quarter worth approximately $9,949,000. 94.69% of the stock is owned by institutional investors.

Insider Buying and Selling at STERIS

In related news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the sale, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This trade represents a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

STE has been the subject of several research reports. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. StockNews.com downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Down 0.2 %

STE opened at $220.43 on Friday. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The firm has a market capitalization of $21.66 billion, a P/E ratio of 46.80 and a beta of 0.84. The company’s 50-day moving average is $213.47 and its 200 day moving average is $223.64. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.03%. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.